Medical Services Completes Additional TB Testing

April 19, 2005
Medical Services International Inc. (OTC: MSITF) wishes to announce that it participated in a TB testing program with a major hospital in China. The test results showed that the VScan TB test had an overall accuracy of greater than 90% with no false positives. Nearly nine million people develop TB disease every year. The vast majority of them live in developing countries where 99% of all TB deaths occur and where 90% of all people living with HIV/Aids live. TB is the number one killer of people with HIV/AIDS. Medical Services is committed to developing a simple test for TB that results in almost instant results and can be used by individuals who do not have necessary health care training and that are far away from laboratory facilities.

Market studies in China show that there is a market for greater than 5,000,000 TB test kits per year. All of the developed countries where individuals are applying for immigration status require a TB test. Current testing available for TB testing is only 40% accurate. The Company feels that there is a significant market for a rapid TB test kit that has the accuracy of the VScan TB test kit.

About VScan ™

The VScan™ rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile, Malaria, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.

For further information contact:
Robert Talbot at 780-430-6363 or
Bill Whitehead, Jr., 416-822-5883

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF".